Clinical Trial Update: Adebrelimab and Chidamide for Pancreatic Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating Adebrelimab in combination with Chidamide for pancreatic cancer, which is currently recruiting in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Chidamide (chidamide)

Snippet

Sponsor: Liu Xiufeng | Conditions: Pancreatic Cancer, Adult | Phase 2 | Status: RECRUITING